🇺🇸 FDA
Patent

US 6503914

Thienopyrimidine-based inhibitors of the Src family

expired A61KA61K31/519A61P

Quick answer

US patent 6503914 (Thienopyrimidine-based inhibitors of the Src family) held by The Board of Regents of the University of Texas System expires Mon Jan 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jan 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
99
CPC classes
A61K, A61K31/519, A61P, A61P19/10, A61P25/00